Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;333:807 (14 October), doi:10.1136/bmj.333.7572.807
| The first 150 words of the full text of this article appear below. |
EDITORI strongly oppose the proposition of Potts et al.1 For all the difficulties of doing high quality randomised controlled trials of some research questions, or in challenging settings, making arbitrary decisions about the "obviousness" of the effectiveness of interventions based on observational evidence cannot be the way forward. This point is well made by the readers with expert knowledge who have already responded about the specific examples described by Potts et al.2
Other readers have criticised the naïveté of the argument but seem to accept the underlying sentiment that the world should not always wait for evidence from randomised controlled trials. This point of view presupposes some method, or criteria, for judging obviousness of effectiveness and merits further consideration.
| |||||||||||
I propose that deciding an intervention is obviously beneficial on the basis of non-randomised evidence requires benefit that clearly outweighs all possible adverse effects (whether frequent
Barnaby C Reeves, reader in epidemiology
Clinical Trials and Evaluation Unit, University of Bristol, Bristol Royal Infirmary, Bristol BS2 8HW barney.reeves@bristol.ac.uk